SINA Corp. (NASDAQ:SINA) on May 21 announced its unaudited financial results for the first quarter ended March 31, 2014. For the first quarter of 2014, SINA reported net revenues of $171.5 million, compared to $126.0 million for the same period last year. Non-GAAP net revenues for the first quarter of 2014 totaled $167.3 million, compared to $121.3 million for the same period last year. Net loss for the first quarter of 2014 was $33.2 million, compared to $13.2 million for the same period last year. Diluted net loss per share for the first quarter of 2014 was $0.52, compared to $0.20 for the same period last year. Non-GAAP net income for the first quarter of 2014 was $11.1 million, versus $1.5 million for the same period last year. SINA Corp (NASDAQ:SINA) net profit margin is 3.50% and weekly performance is 2.30%. On last trading day company shares ended up $45.88. Analysts mean target price for the company is $71.91. SINA Corp (NASDAQ:SINA) distance from 50-day simple moving average (SMA50) is -7.64%.
On June 11, One such stock that you may want to consider dropping is Unilife Corporation (NASDAQ:UNIS), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #4 (Sell) further confirms weakness in UNIS. Unilife Corp (NASDAQ:UNIS) shares advanced 0.35% in last trading session and ended the day on $2.83. Gross Margin is 100.00% and its return on assets is -83.20%. Unilife Corp (NASDAQ:UNIS) quarterly performance is -43.29%.
Insulet Corporation (NASDAQ:PODD) Insider Peter Devlin unloaded 12,314 shares of the stock in a transaction that occurred on Monday, June 9th. The shares were sold at an average price of $37.10, for a total value of $456,849.40. Following the completion of the transaction, the insider now directly owns 67,354 shares in the company, valued at approximately $2,498,833. Insulet Corporation (NASDAQ:PODD) shares moved down -0.75% in last trading session and was closed at $37.04, while trading in range of $36.60 – $37.57. Insulet Corporation (NASDAQ:PODD) year to date (YTD) performance is -0.16%.
Antares Pharma, Inc. (NASDAQ:ATRS) held its Annual Meeting of Stockholders (the “Annual Meeting”) on May 29, 2014. At the Annual Meeting, the stockholders of the Company approved the Amended and Restated 2008 Equity Compensation Plan (the “Equity Plan”). The Equity Plan had been approved by the Company’s Board of Directors on February 11, 2014, subject to stockholders’ approval, and became effective upon receipt of stockholders’ approval on May 29, 2014. The amendments increased the aggregate number of shares that may be issued under the Equity Plan from 15,000,000 shares to 21,000,000 shares, and provided that dividend equivalents granted in connection with stock units or other stock-based awards that are subject to performance goals will be payable only if and to the extent the underlying stock units or other stock-based awards are payable, as determined by the Company’s Compensation Committee. Antares Pharma Inc (NASDAQ:ATRS) ended the last trading day at $3.10. Company weekly volatility is calculated as 4.00% and price to cash ratio as 6.71. Antares Pharma Inc (NASDAQ:ATRS) showed a positive weekly performance of 6.53%.
Medtronic Inc (NYSE:MDT) said on Thursday its minimally invasive heart valve replacement system received U.S. approval to treat patients deemed at high risk for surgery, expanding the eligible patient population for its CoreValve device. Medtronic, Inc. (NYSE:MDT) net profit margin is 18.00% and weekly performance is -2.01%. On last trading day company shares ended up $60.79. Analysts mean target price for the company is $65.63. Medtronic, Inc. (NYSE:MDT) distance from 50-day simple moving average (SMA50) is 1.10%.